|Bid||66.00 x 1200|
|Ask||66.23 x 2200|
|Day's Range||65.49 - 69.45|
|52 Week Range||15.52 - 95.21|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Oct 29, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||92.54|
Brian Garibaldi, JHU Biocontainment Unit Director, joins The Final Round to discuss his thoughts on the rising numbers of cases across the globe and the most recent developments in the vaccine race.
As cases rise globally, Sanofi and GlaxoSmithKline have agreed to provide 20 million vaccine doses to the WHO’s COVAX program and the U.S. has agreed to pay $347 million for 300,000 doses of Eli Lilly’s antibody drug. Yahoo Finance’s Anjalee Khemlani joins The Final Round to discuss the latest on the coronavirus.
Several coronavirus vaccine stocks have slumped as of 11:20 a.m. EDT on Wednesday, dragged down by the broader market sell-off. Shares of Moderna (NASDAQ: MRNA) were 5% lower. Novavax (NASDAQ: NVAX) and Inovio Pharmaceuticals (NASDAQ: INO) were down 6.1% and 4.5%, respectively.